Claritin-d Tablet, Extended Release
Product Images NDC 11523-0102

1 FDA label image from Bayer Healthcare Llc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Claritin-d (NDC 11523-0102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fc008192_claritin-d_claritin-d24_tablets (Fc008192 Claritin D Claritin D24 Tablets)

Fc008192_claritin-d_claritin-d24_tablets (Fc008192 Claritin D Claritin D24 Tablets)
Packaging label for Claritin-D 24 Hour extended release tablets containing loratadine 10 mg and pseudoephedrine sulfate 240 mg nasal decongestant. The label states 10 extended release tablets and is indicated for indoor and outdoor allergies, allergy, and congestion relief. Manufactured by Bayer HealthCare LLC, with dosage instructions and warnings provided on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.